000 | 01831 a2200517 4500 | ||
---|---|---|---|
005 | 20250515114953.0 | ||
264 | 0 | _c20080925 | |
008 | 200809s 0 0 eng d | ||
022 | _a1527-9995 | ||
024 | 7 |
_a10.1016/j.urology.2008.02.050 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMontgomery, Bruce | |
245 | 0 | 0 |
_aVeterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer. _h[electronic resource] |
260 |
_bUrology _cSep 2008 |
||
300 |
_a474-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
650 | 0 | 4 |
_aChemotherapy, Adjuvant _xmethods |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHospitals, Veterans |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatectomy _xmethods |
650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aRadiography |
650 | 0 | 4 |
_aRadiotherapy _xmethods |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLavori, Philip | |
700 | 1 | _aGarzotto, Mark | |
700 | 1 | _aLee, Kelvin | |
700 | 1 | _aBrophy, Mary | |
700 | 1 | _aThaneemit-Chen, Surai | |
700 | 1 | _aKelly, William | |
700 | 1 | _aBasler, Joseph | |
700 | 1 | _aRinger, Robert | |
700 | 1 | _aYu, Wei | |
700 | 1 | _aWhittemore, Alice | |
700 | 1 | _aLin, Daniel W | |
773 | 0 |
_tUrology _gvol. 72 _gno. 3 _gp. 474-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urology.2008.02.050 _zAvailable from publisher's website |
999 |
_c17905648 _d17905648 |